학술논문
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
Document Type
Article
Author
Source
In: The Lancet Diabetes and Endocrinology . (The Lancet Diabetes and Endocrinology, August 2019, 7(8):596-605)
Subject
Language
English
ISSN
22138595
22138587
22138587